Press release
Carcinoembryonic Antigen Industry Continues Growth |Quest Diagnostics, GenWay Biotech
Carcinoembryonic Antigen Market
UK carcinoembryonic antigen market is projected to grow at significant CAGR of 6.7% over the forecast time period. Rapidly increasing geriatric population, technological advancements, and growing healthcare expenditure in the country will promote the market growth.
Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/427
Top Key Players:
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics
• GenWay Biotech Inc.
• Correlogic Systems
• Creative Diagnostics
• Omega Diagnostics Group PLC
• RayBiotech
• and Boster Biological Technology.
Growing cancer prevalence in most of the developing region will be one of the major factors for the carcinoembryonic antigen Industry growth. According to the Cancer Research UK, it is estimated that globally, there will be 27.5 million new cancer cases each year by 2040. Increasing adoption of unhealthy dietary habits leading to obesity and diabetes has escalated the number of people suffering from cancer. Moreover, government initiatives to increase awareness regarding early detection of cancer will fuel the demand for carcinoembryonic antigen tests, thereby augmenting the industry growth.
Growing demand for effective cancer screening services is one of the major market drivers for carcinoembryonic antigen market growth. Carcinoembryonic antigen tests find its application in diagnosis of various cancers including gastrointestinal cancer, breast cancer, lung cancer, ovarian cancer, prostate cancer, and thyroid cancer, thereby driving the global market growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/427
Growth drivers
• Rise in cancer prevalence
• Growing demand for minimally invasive diagnostic procedures
• Recent technological advancements in carcinoembryonic antigen diagnostics
• Increasing per capita healthcare expenditure
Breast cancer Industry is estimated to grow at a substantial CAGR of 7.3% during the forecast period owing to increasing number of cancer deaths among women suffering from breast cancer leading to increasing demand for early cancer diagnosis. According to GLOBOCAN, there were 14.1 million new cancer cases and 8.2 million deaths worldwide in 2013. The percentage of breast cancer attributes to 11.9% of all forms of cancer that form 1.7 million cases throughout the world.
Males in carcinoembryonic antigen market valued around USD 1,003.2 million in the year 2017, due to lifestyle-related factors such as smoking, drinking alcohol, and excessive weight issues are responsible for the largest share of males in carcinoembryonic antigen Industry. Also, according to NHS UK, males are 16% more likely to develop cancer and 40% more likely to die from cancer than women, hence driving the market.
Browse Report Summery @ https://www.gminsights.com/industry-analysis/carcinoembryonic-antigen-cea-market-report
Table of Content:
Chapter 5. Carcinoembryonic Antigen Market, By Gender
5.1. Global carcinoembryonic antigen market share, by gender, 2017 & 2024
5.2. Male
5.2.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
5.3. Female
5.3.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
Chapter 6. Carcinoembryonic Antigen Market, By End-user
6.1. Global carcinoembryonic antigen market share, by end-user, 2017 & 2024
6.2. Hospitals
6.2.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
6.3. Diagnostic Centers
6.3.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
6.4. Cancer Centers
6.4.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
6.5. Research and Academic Institutes
6.5.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast, by region, 2013 – 2024 (USD Million)
Hospitals in carcinoembryonic antigen market is estimated to grow substantially at a CAGR of 6.1% during the forecast timeframe, due to increased geriatric population affected with cancer. Moreover, hospitals have high adoption rates for technologically advanced carcinoembryonic antigen tests that are utilized for cancer diagnosis and management, thereby fueling the growth of market segment.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:.
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carcinoembryonic Antigen Industry Continues Growth |Quest Diagnostics, GenWay Biotech here
News-ID: 1601374 • Views: …
More Releases from Global Market Insights, Inc.
Hepatitis B Vaccine Market Set to Surpass $12 Billion by 2034
The global hepatitis B vaccine market is poised for significant expansion over the next decade, fueled by rising liver disease cases, expanded immunization coverage, and advancements in vaccine development. Valued at USD 6.7 billion in 2024, the market is projected to reach USD 7.3 billion in 2025 and surge to USD 12 billion by 2034, reflecting a healthy compound annual growth rate (CAGR) of 5.7%.
A major driver behind this growth…
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health.
This in turn has led to a surge in demand for various functional foods…
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock.
According to Global Market Insights Inc estimates…
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091
Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group…
More Releases for Carcinoembryonic
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth…
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market?
The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)…
Carcinoembryonic Antigen Market Analysis, Growth Forecast 2024-2033
The new report published by The Business Research Company, titled ""Carcinoembryonic Antigen Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the carcinoembryonic antigen market size has grown rapidly in recent years. It will grow from $1.07 billion in…
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion.
Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain…
Upcoming Trends in Carcinoembryonic Antigen Market till 2016 – 2023
Carcinoembryonic antigens are glycoproteins that play a major role in cell adhesion. Carcinoembryonic antigen is present at very low concentration in healthy adults. Normal carcinoembryonic antigen level in healthy adult is in range between 2.5-5.0 µg/L. Level up may increase due to benign disease or smoking. However, its concentration in serum rise very high in some types of cancer. Hence, carcinoembryonic antigen used as a marker and assist in monitoring…
Carcinoembryonic Antigen Market – Industry Analysis Report, 2016 – 2023
Carcinoembryonic antigens are glycoproteins that play a major role in cell adhesion. Carcinoembryonic antigen is present at very low concentration in healthy adults. Normal carcinoembryonic antigen level in healthy adult is in range between 2.5-5.0 µg/L. Level up may increase due to benign disease or smoking. However, its concentration in serum rise very high in some types of cancer. Hence, carcinoembryonic antigen used as a marker and assist in monitoring…
